Ewha Womans University College of Medicine

Future Ready Ewha Medicine

Notice

Future Ready Ewha Medicine

EWHA NEWS

Ewha Earns Highest Grade for Second Consecutive Year in 2025 University Innovation Support Project Evaluation

Ewha Earns Highest Grade for Second Consecutive Year in 2025 University Innovation Support Project Evaluation Ewha Womans University has once again affirmed its status as a leader in educational innovation by earning the highest rating of S-grade in the educational innovation category of the 2025 University Innovation Support Project Evaluation announced by the Ministry of Education, marking the second consecutive year it has received this top honor, following the 2024 evaluation. In this year’s evaluation, Ewha was recognized for key achievements including: introducing more flexible academic systems to enhance students’ autonomy in choosing their majors; offering Self-designed Module Courses to support student-led learning; establishing major-specific career guidance systems to link academic programs with career and employment opportunities; operating E-Buds, an AI-based intelligent student support system; implementing liberal arts education and a foundational competency certification program to foster future-oriented, interdisciplinary and convergent talent; developing educational innovation courses and encouraging greater faculty participation; and building a communication framework for educational innovation centered on active engagement by members of the university community. Ewha was commended for establishing and advancing a leading model of the autonomous major selection system, which was initiated with the introduction of the Scranton College interdisciplinary major in 2009 and further developed through the implementation of integrated selection for regular admissions by academic division in 2018, thereby laying a strong foundation for cultivating interdisciplinary and convergent talent to meet the needs of future society. As part of efforts to support students’ career exploration and increase flexibility in major selection, Ewha advanced the application period for minors and double majors to the second semester of the first year, enabling students to explore career paths at an earlier stage. It also introduced the Self-designed Module Course System, which allows students to combine short-term courses of their own choosing and receive academic credit as a way to strengthen the foundation for student-led learning. Furthermore, the university systematically provides adjunct faculty-linked major exploration guidance, senior mentoring programs, and other initiatives tailored for students in the autonomous major selection track. The university’s enhanced career and employment support system was also positively recognized. By analyzing career outcome data for each major, it operates a structured career guidance program, while in 2025, it also launched the AI-based intelligent student support system E-Buds to provide personalized career and academic support. In addition, with the goal of cultivating future-oriented, interdisciplinary and convergent talent grounded in strong foundational competencies, the university has systematically designed and implemented initiatives such as developing an integrated liberal arts education framework, offering character education through practical campaigns of sharing, and introducing a foundational competency certification program, while continually strengthening mechanisms for curriculum quality assurance. It also provides major exploration guidance through adjunct faculty and has established measures to expand faculty participation in educational innovation, thereby encouraging more active engagement by members of the Ewha community. Furthermore, to enhance the overall momentum for educational innovation across the institution, the university has built a communication framework through diverse channels for gathering feedback and made efforts to reinforce its performance management structure. President Hyang‑Sook Lee stated, “Ewha Womans University is committed to fostering an educational environment in which students can take the lead in their own growth through flexible, future-oriented academic management that enables world-class higher education. Amid the sweeping tide of advanced technologies, including artificial intelligence, we will continue to pursue educational innovation to nurture creative, convergent talent grounded in inclusive innovation.”
2025-08-08
Ewha Starts to Co-develop AI Platform for Cardiotoxicity Evaluation of New Drug Candidates with Fraunhofer IBMT, Germany

Ewha Starts to Co-develop AI Platform for Cardiotoxicity Evaluation of New Drug Candidates with Fraunhofer IBMT, Germany Ewha has been selected for the “2025 Korea-Germany Industry-Academia Joint Research (2+2 Projects),” overseen by the Ministry of Science and ICT, in collaboration with the Fraunhofer Institute for Biomedical Engineering (IBMT), a world-renowned applied science research institute in Germany. Based on its selection for this large-scale global research project, which is jointly supported by the governments of both nations, Ewha plans to further strengthen scientific and technological cooperation between Korea and Germany. To this end, Jang-Hwan Choi, professor at the Department of Artificial Intelligence at Ewha, and Heiko Zimmermann, director of Fraunhofer IBMT, Germany, have secured a total of KRW 1.87 billion in research funding to jointly develop a next-generation drug cardiotoxicity evaluation platform that combines 3D myocardial organoids and AI over a period of three years starting this October. The contractile dynamics of iPSC-based 3D myocardial organoids are measured with Fraunhofer IBMT’s non-contact optical metrology technology in real time and analyzed with unsupervised AI models from the Medical AI & Computer Vision Lab at Ewha to automatically generate drug dose-response curves. This is expected to enable the high-speed and high-precision prediction of cardiotoxicity risk for new drug candidates at the preclinical stage. To this end, the two organizations signed an MOU in April and established the Ewha–Fraunhofer RegMed AI Hub in Seoul. The Korean Fund for Regenerative Medicine (KFRM) stated that the collaboration will serve as an opportunity to enter the drug development market and establish a global standard platform. The research participants include Ewha Womans University (general management and AI development), Biosolvix Co., Ltd. (organoid production and standardization), Korea University College of Medicine (histopathology and clinical consulting), Dt & CRO (preclinical verification), Fraunhofer IBMT (optical metrology and stem cell platform), and Innovitro GmbH (3D culture process). In particular, Biosolvix will promote the commercialization of research outcomes while carrying out projects of the KFRM. This collaboration was enabled through researcher exchange support projects by the KFRM, including the hosting of an international workshop in 2026, plans for the AI-Organoid Cardiotoxicity Challenge in 2027, completion of preclinical validation, and technology transfer for domestic and foreign pharmaceutical companies and CROs by 2028. Through such efforts, Korea and Germany are expected to strengthen cooperation in the fields of advanced regenerative medicine and AI-digital healthcare convergence, and lead global innovation in cardiotoxicity evaluation.
2025-07-31
College of Business Administration and Graduate School of Business to Achieve Fourth Consecutive AACSB Accreditation

Ewha College of Business Administration and Graduate School of Business to Achieve Fourth Consecutive AACSB Accreditation The College of Business Administration and the Graduate School of Business at Ewha have been accredited for the fourth consecutive time from the Association to Advance Collegiate Schools of Business (AACSB), a global accreditation body for business education. In 2010, Ewha became the first women’s university in the world to receive accreditation across the entire cycle across undergraduate, graduate, and MBA programs. Following the two reaccreditations (2015-2020 and 2020-2025), this latest renewal extends Ewha’s accreditation status to 2025-2030. The AACSB provides the highest level of accreditation for business education, awarding only the top five percent of around 16,000 business schools worldwide. Ewha Womans University is the only women’s comprehensive university to receive accreditation for all stages of business education from undergraduate to graduate level. In an on-site evaluation conducted last May, Ewha was highly rated for its research capacity, globalization, curriculum, and infrastructure. Since its founding in 1964, the College of Business Administration at Ewha has aimed to cultivate global female business executives capable of demonstrating exceptional practical skills in various fields of business management. To this end, the College has developed and offered integrated courses and programs that maximize connectivity with other majors. In line with these endeavors, the College established master’s and doctoral programs in AI & Business Analytics within the Graduate School in 2025 to offer a convergence education in AI and business analytics. Based on this specialized strategy tailored to female leadership and practical training, the College is leading the way in fostering world-class female executives. Launched in 2006 based on its expertise and network in fostering female talent, the Graduate School of Business Administration at Ewha (hereinafter Ewha GSBA) offers a curriculum that combines cutting-edge business theory with a case-oriented education system. It also offers a full-time doctoral program (Doctor of Business Administration, DBA) that teaches scientific management theory and methodology to business managers with extensive practical experience in the field. Notably, the DBA program at the Ewha GSBA, the first of its kind in Korea, cultivates “professionals who can proactively lead changes and innovation” by acquiring the skills necessary to seek innovative management solutions in business environments.
2025-07-25
Pear Blossom Sharing Corps Places Ewha’s Value of Sharing into Practice

Pear Blossom Sharing Corps Places Ewha’s Value of Sharing into Practice Taking the lead in spreading Ewha’s value of sharing through annual summer visits to the Goesan region Receiving enthusiastic responses to various talent donations, including the newly introduced medical volunteer services The fourth Pear Blossom Sharing Corps visited Goesan-gun, North Chungcheong Province, between June 24 and 27, carrying out a wide range of volunteer activities such as education, design, mural painting, and medical services. This volunteer initiative, jointly conducted by Ewha and the Goesan County Office, aims to promote shared growth with the local community and has taken place every summer since 2022. The education volunteer team provided creative education, play and craft activities, and career exploration programs for elementary and kindergarten students at local children’s centers. The design volunteer team developed a logo and mascot character for the Goesan-gun Library. The mural painting volunteer team created an eco-friendly wall mural in Seobu-ri, contributing to the promotion of tourism in the area. Launched this year, the medical volunteer team—comprised of Ewha’s medical school professors, students, and alumnae—offered medical check-ups for the elderly, medication counseling for patients with chronic illnesses, health education, and telemedicine services, while alumnae specialists in obstetrics and gynecology and psychiatry also joined in the efforts. This program was featured in the local media and received positive responses (Watch the video ), while the Goesan County Office expressed its appreciation for the volunteers’ talent donation. Starting with the successful completion of the Pear Blossom Sharing Corps’ volunteer activities, the Volunteer Services Team of the Office of Student Affairs will follow up with educational volunteer activities at home and abroad through the 2025 Ewha Summer Volunteers, embodying Ewha’s founding philosophy of Christian love for neighbors and spearheading the establishment of a more inclusive society.
2025-07-17
Ewha Signs MOU with KIST for Research Cooperation and Talent Development in Future Core Technologies

Ewha Signs MOU with KIST for Research Cooperation and Talent Development in Future Core Technologies Ewha and Korea Institute of Science and Technology (KIST) signed a memorandum of understanding (MOU) in the Conference Room of Pfeiffer Hall on July 14 (Mon.) to promote research cooperation and cultivate talent in science and technology. This agreement was intended to enhance collaboration between academia and research institutions in future core technologies and nurture professionals who will contribute to the advancement of science and technology in Korea. The two institutions plan to pursue collaboration and exchange across all areas, including mutual cooperation and joint research aimed at advancing national R&D programs; mutual exchange of technology and human resources; development of women professionals in science and technology; and co-hosting of seminars, symposia, and conferences on international joint research, along with dissemination of their outcomes. These efforts are based on intensive research cooperation in specialized fields including next-generation semiconductors, AI and robotics, climate and environments, and natural product and new drug development. President Hyang-Sook Lee of Ewha Womans University remarked, “We hope that Ewha’s young and dynamic research personnel, combined with KIST’s extensive research experience, will take the initiative in future core technologies through collaborative efforts in creative and challenging research.” Meanwhile, KIST President Sang Rok Oh stated, “Under KIST’s values of autonomy and openness, we aim not only to fulfill the responsibilities entrusted to us by the nation and society but also to scale up our capabilities by promoting specialized academic and research collaboration with Ewha Womans University.”
2025-07-14
Team Led by Professor Dong Ha Kim Develops the World’s First Bioorthogonal Reaction-based Nanocatalytic Platform...

Team Led by Professor Dong Ha Kim Develops the World’s First Bioorthogonal Reaction-based Nanocatalytic Platform for Cancer Therapy A research team led by Professor Dong Ha Kim at the Department of Chemistry & Nanoscience has successfully developed the world’s first bioorthogonal reaction-based plasmonic-catalytic hybrid nanoplatform for precision cancer therapy. This research finding is gaining attention for enhancing both the precision and reaction efficiency of bioorthogonal reactions—a next-generation technology for precision tumor therapy. The research project was published on July 4 (Fri.) in Advanced Materials, one of the world’s most prestigious materials science journals (top one percent of the Journal Citation Indicator (JCI) Chemistry, Multidisciplinary category). Bioorthogonal reactions refer to a next-generation precision therapeutic strategy that selectively activates drugs in cancer cells without affecting normal cells. Conventional technologies, however, show low reaction efficiency in human physiological environments, while also lacking precise control over the timing and location of drug activation. In order to solve these technological challenges, it was necessary to develop nanocatalysts with higher reaction efficiency and easier controllability. Building on this idea, Professor Kim’s team designed a new nanoplatform that integrates three components: an Au nanoparticle, a Pd nanocatalyst, and a pro-photosensitizer. The novel nanoplatform entails the precise conjugation of Pd particles at the tips of Au nanoparticles, improving both the light absorption of Au and the catalytic activity of Pd. The platform also incorporates the light-responsive allyl carbamate-conjugated methylene blue prodrug, which leads to site-specific drug activation. In particular, this nanoplatform enables precise spatiotemporal control of the prodrug’s cleavage reaction by simultaneously irradiating light at wavelengths of 808 nanometers and 655 nanometers and inducing electron transfer through the plasmonic effect. The research team’s findings confirmed a ninefold enhancement in prodrug activation compared to conventional strategies, while demonstrating precise in-vivo control of the reaction. Both in-vitro and in-vivo studies demonstrated the remarkable tumor-suppressing capability of the bioorthogonal system, which is attributed to the photothermal therapy and photoinduced plasmon electron transfer (PiPET) effects, along with the prevention of leuko-MB formation. Professor Dong Ha Kim predicted that this technology will offer an innovative solution for tumor therapy through precise phototherapeutic strategies. Read the paper: https://advanced.onlinelibrary.wiley.com/doi/10.1002/adma.202418134?af=R
2025-07-10

Future Ready
Ewha Medicine

Promotion Video
Promotion Video